European Patent Office

T 0755/96 (Camptothecin derivatives/RESEARCH TRIANGLE INSTITUTE) of 06.08.1999

European Case Law Identifier
ECLI:EP:BA:1999:T075596.19990806
Date of decision
6 August 1999
Case number
T 0755/96
Petition for review of
-
Application number
90310085.7
IPC class
C07D 491/22
Language of proceedings
English
Distribution
Published in the EPO's Official Journal (A)
Other decisions for this case
-
Abstracts for this decision
-
Application title
Analogue de la 10,11-méthylènedioxy-20(RS)camptothécine et de la 10,11-méthylènedioxy-20(s)-camptothécine
Applicant name
RESEARCH TRIANGLE INSTITUTE
Opponent name
-
Board
3.3.01
Headnote

In ex parte proceedings, Rule 71a EPC gives the Examining Division a discretion to admit or refuse amended claims until a decision is issued under Article 97 EPC. This discretion must be exercised by considering all relevant factors which arise in a particular case and by balancing the Applicant's interest in obtaining a proper patent protection for his claimed invention and the EPO's interest in bringing the examination procedure to a speedy close by the issue of a decision. If in exercising said discretion amended claims are not admitted, the reasons therefore must be given. The assessment that they were filed too late under Rule 71a EPC does not represent an adequate reasoning in conformity with Rule 68(2) EPC.

Keywords
Discretion to admit or refuse amended claims under Rule 71a EPC (yes)
Adequate reasons for not admitting amended claims (no)
Substantial procedure violation (yes)
Reimbursement of the appeal fee (yes)
Remittal to the first instance for further prosecution
Catchword
-

ORDER

For these reasons, it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the Examining Division for further prosecution.

3. The request for reimbursement of the appeal fee is allowed.